Form SCHEDULE 13G RADNOSTIX INC Filed by: Kennerman Associates, Inc.
Tweet
Share
E-mail|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G
|
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
RADNOSTIX INC (Name of Issuer) |
Common stock (Title of Class of Securities) |
(CUSIP Number) |
12/31/2025 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
| Rule 13d-1(b) |
| Rule 13d-1(c) |
| Rule 13d-1(d) |
SCHEDULE 13G
|
| CUSIP No. |
| 1 | Names of Reporting Persons
Kennerman Associates, Inc. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b) | ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
NEW YORK
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
237,489,559.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
42.4 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
IA |
Comment for Type of Reporting Person: (1) 5,000,000 shares of common stock subject to vested stock options exercisable within 60 days of the date hereof and (ii) 26,300,000 shares of common stock issuable upon conversion of the issuer's Series C Convertible Redeemed Preferred Stock
(2) Based on 528,209,538 shares of common stock outstanding as of March 26, 2026 as reported in the issuer's Annual Report on Form 10-K for the year ended December 31, 2025.
SCHEDULE 13G
|
| CUSIP No. |
| 1 | Names of Reporting Persons
GROSSO CHRISTOPHER G | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b) | ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
65,645,540.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
12.1 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person: (1) Includes 5,000,000 shares of common stock subject to vested stock options exercisable within 60 days of the date hereof and (ii) 5,040,000 shares of common stock issuable upon conversion of Series C Preferred Stock.
(2) Includes (i) 2,189,697 shares of common stock and (ii) 2,000,000 shares of common stock issuable upon conversion of Series C Preferred Stock, in each case held by the reporting person's father's, for which the reporting person shares investment control.
(3) Includes (i) 562,884 shares of common stock and (ii) 350,000 shares of common stock issuable upon conversion of Series C Preferred Stock, in each case held by the reporting person's son, for which the reporting person shares investment control.
(4) Based on 523,706,140 shares of common stock outstanding as of March 26, 2026 as reported in the issuer's Annual Report of Form 10-K for the year ended December 31, 2025.
SCHEDULE 13G
|
| Item 1. | ||
| (a) | Name of issuer:
RADNOSTIX INC | |
| (b) | Address of issuer's principal executive offices:
4137 COMMERCE CIRCLE, IDAHO FALLS, IDAHO, 83401. | |
| Item 2. | ||
| (a) | Name of person filing:
Kennerman Associates, Inc. d/b/a Kershner Grosso & Co.
Christopher Grosso
| |
| (b) | Address or principal business office or, if none, residence:
480 Broadway, Suite 310
Saratoga Springs, NY 12866
| |
| (c) | Citizenship:
United States | |
| (d) | Title of class of securities:
Common stock | |
| (e) | CUSIP No.:
| |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
| (a) | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); | |
| (b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); | |
| (c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); | |
| (d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); | |
| (e) | An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E); | |
| (f) | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); | |
| (g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); | |
| (h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); | |
| (i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); | |
| (j) | A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution: | |
| (k) | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). | |
| Item 4. | Ownership | |
| (a) | Amount beneficially owned:
As of the date of this filing, each of Kennerman Associates, Inc. d/b/a Kershner Grosso & Co. and Christopher Gross beneficially own the aggregate number and percentage of common stock of Radnostix, Inc.
As of the date of this filing, Kennerman Associates, Inc. d/b/a Kershner Grosso & Co. had beneficial ownership 237,489,559 shares of common stock of Radnostix, Inc. ("Shares"), including (i) vested options to purchase 5,000,000 Shares that were exercisable within 60 days of the date hereof ("Options"), and (iii) 26,300,000 shares of common stock issuable upon conversion of the issuer's Series C Convertible Redeemable Preferred Stock ("Series C Preferred Stock"). Christoper Grosso is a principal of Kennerman Assocates, Inc., and may be deemed to have beneficial ownership of the Shares and Options beneficially owned by Kennerman Associates, Inc.
The filing of this report shall not be construed as an admission of Christoper Grosso is, for purposes of Section 13(d) or 13(g) of Act or for any other purposes, the beneficial owner of the Shares or Options. Christopher Grosso disclaims beneficial ownership 170,999,219 Shares, Options, Warrants and Series C Preferred Stock covered by this Schedule 13G/A. | |
| (b) | Percent of class:
See Item 11 of each cover page above. %
| |
| (c) | Number of shares as to which the person has:
| |
| (i) Sole power to vote or to direct the vote:
Sole power to vote or to direct the vote: See Item 5 of cover page above. | ||
| (ii) Shared power to vote or to direct the vote:
Shared power to vote or to direct the vote: see Item 6 of cover page above. | ||
| (iii) Sole power to dispose or to direct the disposition of:
Sole power to dispose or direct the disposition of: see Item 7 of cover page above. | ||
| (iv) Shared power to dispose or to direct the disposition of:
Shared power to dispose of or to direct the disposition of: see Item 8 cover page above. | ||
| Item 5. | Ownership of 5 Percent or Less of a Class. | |
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
See Item 4(a) above. | ||
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
Not Applicable
| ||
| Item 8. | Identification and Classification of Members of the Group. | |
Not Applicable
| ||
| Item 9. | Notice of Dissolution of Group. | |
Not Applicable
| ||
| Item 10. | Certifications: |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
|
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Radnostix revenue falls 27% amid product recalls and FDA actions
- Radnostix, Inc. Reports FY2026 2nd Quarter and Six Months Results - Completes Execution of FDA 483 & Recall Actions, Restores Capsule Inventory, Completes Lucerno Dynamics Asset Acquisition
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
13GSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
